[PLX] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
09-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -111.79%
YoY- -43.97%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 10,439 4,553 2,889 679 5,097 7,383 3,968 17.48%
PBT -7,264 -9,400 -59,148 -8,526 -5,972 -7,345 -4,321 9.03%
Tax 190 132 2,087 314 28 38 0 -
NP -7,264 -9,400 -59,148 -8,598 -5,972 -7,345 -4,321 9.03%
Tax Rate - - - - - - - -
Total Cost 17,703 13,953 62,037 9,277 11,069 14,728 8,289 13.47%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -69.59 -206.46 -2,047.35 -1,266.27 -117.17 -99.49 -108.90 -7.18%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -0.49 -0.65 -4.75 -0.09 -0.06 -0.08 -0.05 46.26%
EPS Diluted -0.49 -0.65 -4.75 -0.09 -0.06 -0.08 -0.05 46.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.